Japan team treats chronic kidney disease with iPS cells in mice

Kyoto University's research team has successfully used human induced pluripotent stem cells (iPSCs) to prevent kidney disease in mice, paving the way for potential therapies for chronic kidney disease in humans. The team plans to conduct clinical trials on transplant patients and others within a few years. Currently, around 20 million people in Japan suffer from chronic kidney disease, with only about 2,000 receiving new kidneys annually due to donor shortages. This breakthrough could significantly address the shortage of donors and revolutionize regenerative medicine for treating this condition.